Congress blocks OMB grant control in spending deal
Congress paused OMBโs plan to centralize federal research grant approvals under a president-appointed panel, fearing political interference with the long-standing peer-review system. The $200 millionโฆ
Congress has paused the Office of Management and Budgetโs plan to overhaul how federal research grants are awarded, after lawmakers raised concerns that the new rules would give politicians too much control over funding decisions. The pause comes after a week of hearings in the House Committee on Science, Space, and Technology, where scientists and university leaders warned that the proposal could undermine the peerโreview system that has guided U.S. research funding for decades.
The OMB had proposed a new framework that would centralize grant approvals in a small advisory panel appointed by the President. The plan was meant to cut administrative costs and streamline the process, but critics say it would replace expert evaluation with political judgment. The proposal also sought to give the Department of Commerce a larger role in deciding which projects receive money, a move that many in the scientific community view as a threat to the independence of research. The pause follows pressure from the National Academies, the American Association for the Advancement of Science, and dozens of university presidents who testified that the change could lead to funding being allocated based on policy preferences rather than scientific merit.
The OMBโs draft budget argued that the new system could save about $200 million over five years by reducing the number of grant review panels. However, the proposal would also require new oversight committees and a more extensive reporting regime, potentially adding bureaucracy. In the hearings, Senator Maria Cantwell said the changes โwould shift the science funding process from experts to politicians,โ while Dr. Eric Lander, former director of the National Institutes of Health, warned that the proposal could erode trust in federal research agencies. The pause means the OMB must revise its draft or seek congressional approval before any changes can be implemented.
The next step is for Congress to decide whether to adopt the OMBโs plan, modify it, or reject it entirely. The pause gives lawmakers time to draft alternative legislation that preserves peer review while addressing administrative costs. The outcome will shape how basic and applied research is funded for the next decade, affecting everything from climate science to biomedical breakthroughs. The debate highlights the delicate balance between efficient government oversight and the need for independent scientific judgment.
Read Full Story at Ars Technica โ


